rh.wo&tPd with twlolts catheter reuse strategies. The potential to reduce cost was the major motivating factor for many centers in Europe, South America, Asia and Cana:'a to reuse percutaneous transhrminal coronary angiopksty catheters In Canada, a survey was conducted among all of the 46 centers that provide cardiac cathetetition. Of the 44 centers that responded, 3% of hospitals reuse cardiac catheters (1) . Using data from two hospitals in Montreal, the Council for Health Techaologies in Quebec (2) estimated that when a balloon catheter was reused two times, the estimated savings was $750 per procednre. In 1994, -420,OOtl coronary angioplasty procedures were performed in the United States (3) . At an average charge of $16,000 per procedure (4) . the initial hospitalization charges amounted to more than $6 billion. Although much of the etptipat used for coronary angioplasty is expensive, under direction of the Food and Drug Admit&ration, coronary angiaplasty equipment is labeled "for single use *; therefo:e, reuse is not currently practiced ir, the United States. At
The %est case* sceoario olked a potential savings of$4t?@ (5.5% of total in-hospital cwst), whereas the %orst case* wnario resulted la an increased cwt of $1#75 (12.2% of total in-hospital cat) compared wltb the single-w strategy. Cost of the %kely case"sceoahwassimilartotbatofthesingle-oses&a~. Sensii anatyses i&Wed the ditfefent rates of rem --tionaadcostoftlallooacathetelsrequlredtoolFsetpotential rmvingsineachstrategy.
Cd.
Altlloagh mlslng cmmlaJy an@oplasty catkters may reduce total in-hospital cost& even a modest increase in eo~ti0n.q req&lug mqjent rewsc&btion may o&t any potenttal savlags. Ekrcpnrr, if all increase la complk&lons and fKOCEdlUOtilllOCMkavoided,thereil%strategplUJSSlgld6~Dt
CT.0llOlldCpoteetkdM~nltinlatefy.lMybOXtMd~tOotber jmstaneous coronary ioterventlom3l equipment.
(JAI0 cdl c47niid 1996;28:106-11) the Cleveland Clinic, potentially reusable coronary angioplasty equipment was estimated to comprise -18% of the total cost (5) . If coronary angioplasty equipment could be reused, the total cost could potentially be reduced by more than $1 billion per year in the United States.
Recently, in the only publi&d prospective study on the topic, Plante et al. (6) compared the experience of a Quebec hospital that reused catheters with that of a single-use center in Toronto. Procedural success rates were similar in both centers (88%) Over the IO-month study period, the estimated savings was $258 per patient in the reuse center. However, these estimated savings might have been offset by the higher amount of contrast agent and the greater number of balloon catheters used, as well as by the increased complication rates, which resulted in a greater need for urgent revascularization (Table  1) . To explore the potential cost savings of various strategies of coronary angioplasty catheter reuse, we devised three theoretical cost models based on the findings of the study by Plante et al. (6) and actual coronary angicplasty costs at the Cleveland anii.
. Table 1 ). The mst in these models was calculated for different numbers of balloons and different rates of urgent revascularization. Patients experiencing abrupt vessel &sure outside the cardiac catheterization laboratory were assumed to return to the laboratory for urgent coronary angiopIasty. Guide wires wete assumed not to be reusable because they are fragile arid needed to be shaped for each lesion. As the number of guiding catheters used in both Canadian centers was approsimately the same, and because of the mst was relatively low ($70 to $!90), they were not considered as a separate mst item. Although the amount of mntrast agent used was significantly higher in the reuse center compared with the single-use center, the mst difference was small ($15) in relation to the total mst of the procedure CABG=axomyarteqbypasgsh~NA=notap+abk.
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CATlfEl-ERS (S,!JfM); therefore, we assumed that a similar amount of contrast agent was used in all the three scenarios.
'WcM Case"Scenatio. The rates for urgent coronary angjoplasty and coronary artery bypass graft surgery and the number of balloon catheters used were assumed to be similar to those remrded For the reuse center r.hle 1). Only 80% of the balloons were assutned to be reusable, because after each use, changes in shape and profile could adversely affect performance. Balloon catheters were as!.umed to be reused twice based on data from the Council of Health Technologies in Quebec (2) showing that the largest incremental savings were achieved after two reuses.
"Besl case" scenario. In this scenario, the rates for urgent coronary angioplasty and urgent bypass surgery and the number of balloon catheters used were assumed to be similar to those reported for the single-use center ( Table 1 ). AU balloons were asswned to be reusable, which is mnsistent with the estimate provided by the Council of Health Technoiogks in Quebec (2) . In the study by Piante et al. (6) , baboon catheters were reused an average of 5.4 times; therefore, in this scenario tive reuses were assumed.
"Likes cast" SC&. This scenario was mnstructed in an attempt to ilbtstrate the likely scenario associated with catheter reusebecauseofthedifferencesinchnicalsettinganddRation strategies between the two centers (6) . Rates for urgent coronary angioplasty and urgent bypass surgery and the number of balloon catheters used were assumed to be the average of those of the single-use and the reuse center (Table 1 ). It is likely that not ah bafloon catheters muid be reused, therefore, &I% were assumed to be reusable.
Cmwnary s8gioplstg. From June to Cktober 1994, at the Cleveland Clinic Foundation, a total of 1,516 balloon catheters were used at a total mst of $781373. The average mst of each catheter was $515. Over the same pet&r& 60% of the contrast agent used for mronaty angioph&y was ionic and 40% was nonionic. At a cost of $0.03 per miifihter of ionic mntrast agent and $1 per miflihter of nonionk mntmst agent, the average mst for each miUiliter of mntrast agent used was Eo.42. The, mst for rester&zing and repackagjng each catheter was estimated to be $20 (6) .
Duringthesameperiod,477baUoonangiophistyproeedures were perfortned. Costs were determined by the Transition System Incorporated hospital acmunting program, which cakulatedfisedandvariabfemstsofmsounesmnsumed inchding prof&onai and hospital setvices, using a bottom-up approach ($7). Professional m&were based on actual salarks and benefiti of -fT and indirect msts such as overhead and insumnm. Disposllble supplies, nonphysjcian iabor and indi-Rxtmslsaladetptllehaspitaloostslllescquisitioncosta were used for dkposabie supphes. IUonphyskian labor, such as nursing and secretarial sakes as wefi as benet?& were obtaheddiifromthesalatyseheduleandapportioned 55% variable (based on the duration of time spent in the Qtheterizatioakbomtoryandilltensivecareunitalldon regular nwsing Boots) and 45% fkerf per promdure. fndirti hospital oosts, iocEnding major capital deprecistion and over-head, were allocated based on factors such as patient volume and square footage. The median cost was Sg$OO with a standard deviatioo of $11,031. We used the cost difference between ekctive coronary angioplasty and eiedive with subsequent urgent coronary ang&lasty to compute the additional ro%t for urgent coronary angioplasty. Of the patients undergoing elective with subsequent urgent coronary angioplasty, the median cost was 522,657. Therefore, the cost of an urgent coronary angioplasty procedure was assumed to be $13,857. Similarly, the cost diIIerence between elective coronary angio-pIasty and elective coronary angiophtsty with subsequent urgent bypass surgery was used to compute the additional cost for urgent bypass surgery. Of the patients undergoing elective coro,uuy angioplasty requiring subsequent urgent bypass surgery, the median cost was $36,167. As such, the cost of an urgent coronary angioplasty procedure was assumed to be S27367.
SensItIvity analgsis. Sensitivity analyses were performed on the three models based on different rates of urgent revastadarimtion. To express the rates of urgent coronary angiophty and bypass surgery as a single rate of revascuIarixation, an index-"unit of revascuk&ation"-was used. This unit was based on tbe rates for urgent coronary angioplasty (4.1%) and bypass surgery (3%) in the reuse center of the study by Plante et al. (6) (Table 1 ). Hence, the proportions or revascularixation procedures made. up by coronary aogioplasty and bypass surgery were 42% (3.On.l) and 58% (4.1/7.1), respectively. These proportions were similar in the single-use catheter. The cost of each "unit of revascularixation" was then computed as the sum of 42% of the ast of an urgent coronary angioplasty procedure and 58% of the cost of urgent bypass surgery. Using the amespondii costs at the Cleveland Clinic, each "unit of mtion" was $217 per patient. This index simplified presentation of the cost analysb and rates of revascularization.
In addition to the rates of revascularixation, the cost of balkm catheters was used to determine in-hospital cost. Sensitivity analyses were also performed on the three models based on d&rent costs of balloon catheters. In each model, tbe difference between the reuse and single-use strategy was cahhted with the cost of balloon catheters ranging from $200 to $700, which was the approximate range of costs for ,a balioon catheter at the Cleveland Clinic. A positive value was the amount associated with increased cost from the reuse strategy, and a negative vaIue was the amount associated with potential savings from the reuse strategy.
Results
0veraII In&ospItaI e&s. We found that in-hospital costs varied substantially with each, reuse strategy. Reuse of coronary augioplasty catheters may be associated with a potential savings of $Qso (5.5%) or an increased cost of $1,075 (12.2%) of the total idospital cost for each patient (Table 3) . Etecause the primary consideration was the c~st-ehcy of reuse of ~~themaximalpomibIesavingswasthecostofnew cAtheM& representing $618 per patient. The maximal poten-JACC Vol. 28. No. 1
July 199&106-11 W3 8,929 c4BG = cornnary anay bps graft surgery; FTCA = pcrcinantranslumiaat coronary angioP@y. tial savings in our models was ,$480, which was 78% of the cost of new catheters. In contrast, if the number of catheters used and rates of revascularization were significantly higher than those-in the single-use strategy, reuse may be associated with costs greater than 70% of the cost of new catheters.
The relative costs of balloon catheters and urgent revascularixation procedures varied markedly among the different strategies. In the single-use strategy, catheters comprised 7% ([$618/$8,800] X 100%) of the total in-hospital cost. On the other hand, based on our models, the cost of reusing catheters, including resterilixation, accounted for 1.5% ([$123/$8,320] X 100%) to 5.4% (($538/$9,875] X 100%) of the respective total m-hospital cost ( Table 3 ). The cost for urgent revascularixation was 3.5% for the single-use strategy, whereas the cost of urgent revascularixation ranged from 4.8% to 15.6% of the respective total in-hospital costs in reuse strategies. As the cost of revascularization was much higher than the cost of catheters, it was not unexpected that the rates for urgent revascularixation were the principal determining factor for the diiIerences in cost among diierent reuse strategies.
Seositlvlty analysis. Sensitivity analysis showed that potential savings could be lost if the rates of revascularixation were only 2 to 4 "units," depending on the reuse strategy (Fig. 1) . The "worst case." scenario allowed for the lowest rates of urgent revascularixation (i.e., 2 "units of revascularixation"). Therefore, for this scenario to afford any potential savings, the rates of urgent coronary angioplasty and urgent bypass surgery should not exceed 1.1% and 1.2%, respectively.
The "likely case" scenario was constructed to project the most probable outcome associated with reuse of coronary angioplasty equipment. In the single-use strategy, there were 1.8 "units of revascuh&ation,'~ compared witb 3.3 in the "likely case" scenario. Therefore, to offset the potential for savings, the rates of revasslrrization wou!d need to be almost doubted.
Sensitivity analysis based on the cost of tbe catheters showed that the potential for savings was more likely when the catheter cost was higher (Fig 2) . However, this was related to the expense of urgent mvascularixation. When tbe rate of revascub&ation is low (as in the "best case" scenario), the catheter cost that results in potentiaI savings is reduced. In the "IikeIy case" scenario, the cat of baIIoon catheters needed to be ahnost $700 for the totaI cost to equal the singIe-use strategy. 
Discu~~sion
Although experimental and clinical data suggest that catheter reuse may not be associated with an increased risk of morbidity and mortality to patients, including tbe rkks of equipment breakage (8), particulate body embolizatioo (8, 9) , infection (6, (10) (11) (12) (13) (14) , endotoxic reaction (15) and toxicity (16) , the cost-benefits of catheter reuse strategies have not yet been closely evalyated. It has bee0 assumed that retIs would be associated with substantial cost savings (2, 6, 17) . Our study was designed to determine the potential for cost savings in the thcorcticai catheter reuse models. Our modeling was instroctive in that if catheter reuse is associated with an even modest increase in ciinical complications, any potential savings would be lost.
Although the Council for Health Technologies in Quebec
(2) estimated savings of $l,UMJ (Canadian) per procedure, thk savings was calculated based only on the cost of balloon catheters and resterilhatioo and the omnber of Limes the catheter was reused. In that model all catheters were armed to be reusable. The possible ditferences in performance sod outcome associated with reused catheters were not considered.
Our study examined the factors ad found that the rates of rev-0 were qcial in determinhg potential savings in a reose strategy. IO a detailed cost anaiysii of percutane-ous coronary re.vascularizatioo, urgent bypass surgfq was estimated to increase cost by 37% (5) . Tberefore, potential savings in a reuse strategy depended largely on the rates of urgent revascularizatron. Of note was that the rate of adverse eveots between the singie-use and reuse centers was similar (2.5% and l.l%, respectively) in the subgroup of patients with stable angina. Ahbougb this tiding suggeds that reuse is more likeb to be cost-effective for these patieo~ a much larger number of patients is oeeded for con6rmation. Prevhsstu&s.Therea~~fortbebigherrateofcomplications in the stody of Plante et aL, which resulted in heasedratesofnxscuhhthinthereueceoter,may have been &et the pmporth of patients with acute coromuy sy&omeswas3O%higber (6) .DatafromtbeNationalHeart, Lung, and Blood Institute's Percutaaeous Traosluminal Coremy AnghpMy Registry (18) reported that the chaoce of pmiprocedmal occlusion in patients with acxite -nary syn-dromewas6O%bi&erthaninpatieotswitbstabkangha pedork. iu addition, EUk et al. (5) found that coronary angbpky in patkots with recent myocardial ihrctioo in-creasedcostby17%.Anotberreasonfortbehigherrateof complications in the reuse center may have been the higher chauce of~traoma to the vascL Crossing protIle was higher with reused catheters bfxause they lose the lubrkated surface ooatingsanddonotwrapasweUasnewcatktets.Rensed catheters mytired more eat&e maniptda~ that new catheters, which may bate induced ,vx%-f intraiasclllar trauma (6) .
Tlie strong association of in-hospital cxnphtions with bospitalcostkweUdoamxnted.GhenetaL(19)cwtpered tJ~axtsforcom~otiooalang@hty,direchnalatberectomy ~stentingin211patients.TbecostofsteatiogwaSsig0ili-cantlyhi&erthanconventionai athereuomybecaoseofthevpscularmm&gfterstent-ing. The greater cost incurred was the result of longer hospital stays, more laboratory tests and more blood bank services. In the setting of catheter reuse, moderate savings could be wed if the complication rate5 were not significantly increased compared with a single-use strategy.
Ballooa catheters. In our models, the different number of balloons in each of the strategies affected the potential cost savings. The number of balloons used per lesion in the "worst case" scenario was twice that of the single-use strategy. This finding may be partly explained by the higher failure rate of reused balloons in crossing lesions (10.2% vs. 3.3%) in the Canadiin study (6) . In addition, the greater number of balloons used may reflect diierent dilation strategies in the single-use and reuse centers. Operators in the reuse centers used undersized balloon catheters first, increasing the balloon size as needed, because they believed that this strategy was safer and that the balloons were cheaper (ti). The total number of balloon catheters used to treat a lesion may not be significantly diierent between new and reused catheters (as assumed in the "best case" scenario). In fact, Rozenman et al. (20) reported from a center that routinely reused catheters that the average number of balloon catheters used per lesion was 1.3. This was similar to the average number of balloon catheters used per lesion in the single-use center of Plante's study (6) . However, in this study (20) , balloon catheters were only reused once and the number of lesions treated for each patient was greater, making comparison between these two studies difficult.
The number of times a catheter could be reused may be related to the potential for savings. Although the Council for Health Technologies in Quebec (2) suggested that the incremental savings from catheters after three uses was minimal, we found that reuse up to five times was associated with substantial savings. For exampIe, in the "likely case" scenario, to afford savings, the cost of catheters would have to increase from $279 to $402 per patient if catheters were reused twice instead of fie times (with only 80% of the catheters reusable). This increase represented an increased cost of approximately 44% for balloon catheters.
However, balloon catheters made up only 7.4% of the total in-hospital cost. This was a relatively small proportion of the total, and therefore potential savings could be easily affected by the rates of expensive revascularization procedures. From the sensitivity analysis using the cost of catheters, it was clear that potential savings depended largely on the reuse strategies. In a strategy with high complication rates, potential savings would be unlikely. On the other hand, with low complication rates, the chance for potential savings increased. In addition, we have also shown that as the cost of catheters fell, so dii the likelihood that a reuse strategy would be associated with a reduction in cost.
Pmeednre t&. Another important consideration in resource utilization is procedure time, With the reuse strategy, procedure time was 13 min (20%) longer than with the single-use strategy (6) (Table l}, which was probably the result of diiferences in technique for dilation and increased technical JACC Vol. 28, No. I July 1996:106-11 difficulty (i.e., increased crossing times and failure rates).
Lengthening procedure time reduces the number of patients that can be treated and therefore increases cost. In addition, treatment of other patients may be delayed. Ellis et al. (5) estimated that a delay in treatment could increase cost by 6!% lo 86%. Prolonged procedure time was also associated with an increase in the event rates of death, myocardial infarction and subsequent need for revascularization after coronary angioplasty or directional atherectomy after 6 months (21). In this Erst rxge-scale randomized trial alping an antagonist to platelet glycoprotein receptor IIb/IIIa, trlere was a 9% increase in these events for every 30 min of incre,lszd procedural time.
Study limitations. Because the results of this study are based on theoretical models, there are several potential limitations. First, the clinical data were obtained from a nonrandomized study from two different centers in Canada. There were distinct differences in the clinical settings, medical treatment strategies, angioplasty practice patterns and operator experience between these two centers, which could have affxted the findings of the study. In addition, the CUrrent practice of using stents to treat threatened or abrupt vessel closure may reduce the need for urgent revascularization procedures, and possibly cost. More recently, the preliminary results of a prospective randomized study (22) suggested that reuse of coronary angioplasty catheters was not associated with increased rates of urgent revascularization in 1,033 procedures. A total of 753 (73%) procedures were randomized to reused catheters. The rates of crossing :he lesion were similar between patients receiving new and reused catheters. As the majority of the patients in this study had unstable ischemic syndromes, the rates for urgent bypass surgery were higher-5.7% for new catheters and 5.3% for reused catheters. Out-of-laboratory abrupt vessel closure was 0.7% and 1.2% for patients receiving new and reused catheters, respectively. Similarly, a study from an Israeli center that reused balloon catheters (20) showed that adverse complication rates were got prohibitive.
Second, several assumptions were made in formulating the ----Im.. models. These assumptions, such 3; :hi prVpLLIvII of ca:h;ters that could be reused, number of balloons used and rates for urgent revascularization in the various case scenarios, would require a randomized trial for verification. Such a trial would require at least 7,700 patients in each of the two groups to detect a minimal cost difference of $500 per patient, based on the standard deviation of $11,031 with a power of 0.8 and (Y of 0.05. However, the three models and sensitivity analyses probably accurately reflect the spectrum of possible results of a prospectiye trial.
Third, the long-term results of coronary angioplasty employing reused catheters are unknown. If the resteoosis rate is higher with reused catheters, these patients may require repeat procedures, therefore increasing cost.
Finally, we did not consider other devicks used for percutaneous coronary intervention, such as intravascular ultrasound, high speed rotational or diiectional athenxtomy and laser ablation, which are at least two to three times more expensive than balloon catheters. These devices are finding their niches in intervendonal cardiology and their use is increasingly common. For example, intravascular ultrasound imaging is frequently used after ooronary stenrmg to ensure adequent strut expansion and apposition (U), and high speed rotational atherectomy is used for calcified lesions (24) . In addition, several burrs of diierent sires may be used in a single patient, and balloon angioplasty is commonly used as an adjunct procedure. Therefore, if reuse of these devices could be shown to be safe and efficacious, potential for savings would be increased in both the absolute and relative (-20% of total cost) amounts (5) .
Conelusions. Our study was designed to evaluate the costeffectiveness of reusing coronary angioplasty balloon catheters. We came to the conclusion that even a modest increase in complication rates associated with reused catheters would potentially negate any savings. These results suggest that a catheter reuse program should only be implemented if complication rates are no greater than those associated with new catheters. Of note, preliminary data from a recent randomized trial suggested that reuse of coronary angioplasty balloon catheters was not associated with an increase in complication rates. Although the maximal possible savings would be the cost of the new catheters reuse of percutaneous coronary interventional equipment may be extended to include rotablator burrs, intravascular ultrasound catheters and other expensive, currently labeled "single-use only" products.
